These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31283084)

  • 1. Do chorionic villus samplings (CVS) or amniocenteses (AC) induce RhD immunisation? An evaluation of a large Danish cohort with no routine administration of anti-D after invasive prenatal testing.
    Kristensen SS; Nørgaard LN; Tabor A; Sundberg K; Dziegiel MH; Hedegaard M; Ekelund CK
    BJOG; 2019 Nov; 126(12):1476-1480. PubMed ID: 31283084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation--outcome of a new antenatal screening and prevention program.
    Tiblad E; Taune Wikman A; Ajne G; Blanck A; Jansson Y; Karlsson A; Nordlander E; Holländer BS; Westgren M
    PLoS One; 2013; 8(8):e70984. PubMed ID: 23940682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of first trimester non-invasive fetal RHD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis.
    Neovius M; Tiblad E; Westgren M; Kublickas M; Neovius K; Wikman A
    BJOG; 2016 Jul; 123(8):1337-46. PubMed ID: 26663771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal RHD genotyping in maternal serum during the first trimester of pregnancy.
    Costa JM; Giovangrandi Y; Ernault P; Lohmann L; Nataf V; El Halali N; Gautier E
    Br J Haematol; 2002 Oct; 119(1):255-60. PubMed ID: 12358932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of fetal loss after chorionic villus sampling in twin pregnancy derived from propensity score matching analysis.
    Gil MM; Rodríguez-Fernández M; Elger T; Akolekar R; Syngelaki A; De Paco Matallana C; Molina FS; Gallardo Arocena M; Chaveeva P; Persico N; Accurti V; Kagan KO; Prodan N; Cruz J; Nicolaides KH
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):162-168. PubMed ID: 34845786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis.
    Koelewijn JM; de Haas M; Vrijkotte TG; van der Schoot CE; Bonsel GJ
    BJOG; 2009 Sep; 116(10):1307-14. PubMed ID: 19538414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of fetal loss following amniocentesis or chorionic villus sampling in twin pregnancy: systematic review and meta-analysis.
    Di Mascio D; Khalil A; Rizzo G; Buca D; Liberati M; Martellucci CA; Flacco ME; Manzoli L; D'Antonio F
    Ultrasound Obstet Gynecol; 2020 Nov; 56(5):647-655. PubMed ID: 32632979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study.
    Tabor A; Vestergaard CH; Lidegaard Ø
    Ultrasound Obstet Gynecol; 2009 Jul; 34(1):19-24. PubMed ID: 19504504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total pregnancy loss after chorionic villus sampling and amniocentesis: a cohort study.
    Bakker M; Birnie E; Robles de Medina P; Sollie KM; Pajkrt E; Bilardo CM
    Ultrasound Obstet Gynecol; 2017 May; 49(5):599-606. PubMed ID: 27255564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The loss rates for invasive prenatal testing in a specialised obstetric ultrasound practice.
    Scott F; Peters H; Boogert T; Robertson R; Anderson J; McLennan A; Kesby G; Edelman D
    Aust N Z J Obstet Gynaecol; 2002 Feb; 42(1):55-8. PubMed ID: 11926642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women.
    Darlington M; Carbonne B; Mailloux A; Brossard Y; Levy-Mozziconacci A; Cortey A; Maoulida H; Simon T; Rousseau A; Durand-Zaleski I;
    BMC Pregnancy Childbirth; 2018 Dec; 18(1):496. PubMed ID: 30547830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput, non-invasive prenatal testing for fetal Rhesus D genotype to guide antenatal prophylaxis with anti-D immunoglobulin: a cost-effectiveness analysis.
    Saramago P; Yang H; Llewellyn A; Palmer S; Simmonds M; Griffin S
    BJOG; 2018 Oct; 125(11):1414-1422. PubMed ID: 29415334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland.
    Haimila K; Sulin K; Kuosmanen M; Sareneva I; Korhonen A; Natunen S; Tuimala J; Sainio S
    Acta Obstet Gynecol Scand; 2017 Oct; 96(10):1228-1233. PubMed ID: 28718198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procedure-related risk of miscarriage following chorionic villus sampling and amniocentesis.
    Beta J; Zhang W; Geris S; Kostiv V; Akolekar R
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):452-457. PubMed ID: 30977213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (2) Invasive Diagnostic Testing for Fetal Chromosomal Abnormalities.
    Lee JY; Kwon JY; Na S; Choe SA; Seol HJ; Kim M; Kim MA; Park CW; Kim K; Ryu HM; Hwang HS; Shim JY
    J Korean Med Sci; 2021 Jan; 36(4):e26. PubMed ID: 33496085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study.
    Slootweg YM; Zwiers C; Koelewijn JM; van der Schoot E; Oepkes D; van Kamp IL; de Haas M
    BJOG; 2022 Sep; 129(10):1721-1730. PubMed ID: 35133072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Foetal Rhesus-D typing added to antenatal screening for infectious diseases and erythrocyte immunisation].
    van der Ploeg CP; Hirschberg HJ; de Haas M; Abbink F
    Ned Tijdschr Geneeskd; 2015; 159():A8315. PubMed ID: 25898866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis.
    Akolekar R; Beta J; Picciarelli G; Ogilvie C; D'Antonio F
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):16-26. PubMed ID: 25042845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chorionic Villus Sampling, Early Amniocentesis, and Termination of Pregnancy Without Diagnostic Testing: Comparison of Fetal Risk Following Positive Non-invasive Prenatal Testing.
    Zelig CM; Knutzen DM; Ennen CS; Dolinsky BM; Napolitano PG
    J Obstet Gynaecol Can; 2016 May; 38(5):441-445.e2. PubMed ID: 27261219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis.
    Salomon LJ; Sotiriadis A; Wulff CB; Odibo A; Akolekar R
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):442-451. PubMed ID: 31124209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.